| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fd4c6f4db64e28dcf21de06aad8b08f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c8a5d41cb6528c52710e282bf87a0ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 |
| filingDate |
2009-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e69ed55206eaab68bb3afbb1d04614d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32cca853c8333ee3dc568e1c58cf0ed6 |
| publicationDate |
2009-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009108755-A2 |
| titleOfInvention |
Pharmaceutical combinations for the treatment of cancer |
| abstract |
This invention relates to pharmaceutical compositions for the treatment of cancer comprising a src kinase inhibitor and an HDAC inhibitor. It also relates to methods of treating cancer in a mammal by administering a src kinase inhibitor in comnbination with an HDAC inhibitor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3034076-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11633486-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013522251-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109758461-A |
| priorityDate |
2008-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |